Johnson & Johnson Unveils Promising Long-Term Results for IMAAVY® in Generalized Myasthenia Gravis Patients #USA #Johnson_&_Johnson #Spring_House #Myasthenia_Gravis #IMAAVY
@newsen.bsky.socialExplore
@newsen.bsky.social@newsen.bsky.socialKlygefa®: A New Hope for Adults with Generalized Myasthenia Gravis in Japan #Japan #Myasthenia_Gravis #Minato-ku,_Tokyo #Klygefa #Alexion_Pharma